Specifically, GLP-1 activity has been observed in areas like 8: The hypothalamus, which regulates appetite The brainstem, which connects gut signals to the brain The limbic system, including the nucleus accumbens and ventral tegmental area, which are involved in reward and cravings Through these pathways, GLP-1 medications may: Reduce food cravings and food noise Change how rewarding certain foods feel Lower motivation to seek out highly palatable foods There is also emerging interest in whether these effects extend beyond food
Essentially, longevity gurus and their followers are taking their chances, betting that people like Baker are wrong.
The dose titration starts at 0.25mg and increases every four weeks through 0.5mg, 1mg, 1.7mg, and 2.4mg, then continues up to 3.6mg and the maintenance dose of 7.2mg at around week 32
Note any reactions at the injection site , and if needed, document them for your healthcare providers review
it's the absolute foundation of valid data
The k red app values for the D90 and K26 mutants at 5 mM GSH were 78 and 5.6% of the k red app value for PfGrx C32S/C88S as a control
